BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 7666550)

  • 1. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
    Campbell S; Vogt VM
    J Virol; 1995 Oct; 69(10):6487-97. PubMed ID: 7666550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.
    Bennett RP; Nelle TD; Wills JW
    J Virol; 1993 Nov; 67(11):6487-98. PubMed ID: 8411352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolytic activity of purified avian sarcoma and leukemia virus NC-PR protein expressed in Escherichia coli.
    Séllos-Moura M; Vogt VM
    Virology; 1996 Jul; 221(2):335-45. PubMed ID: 8661444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli.
    Joshi SM; Vogt VM
    J Virol; 2000 Nov; 74(21):10260-8. PubMed ID: 11024160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus.
    Gross I; Hohenberg H; Kräusslich HG
    Eur J Biochem; 1997 Oct; 249(2):592-600. PubMed ID: 9370371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Structure of Immature Virus-Like Rous Sarcoma Virus Gag Particles Reveals a Structural Role for the p10 Domain in Assembly.
    Schur FK; Dick RA; Hagen WJ; Vogt VM; Briggs JA
    J Virol; 2015 Oct; 89(20):10294-302. PubMed ID: 26223638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Rous sarcoma virus Gag particles assembled in vitro.
    Yu F; Joshi SM; Ma YM; Kingston RL; Simon MN; Vogt VM
    J Virol; 2001 Mar; 75(6):2753-64. PubMed ID: 11222698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays.
    Berkowitz RD; Luban J; Goff SP
    J Virol; 1993 Dec; 67(12):7190-200. PubMed ID: 8230441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles.
    Campbell S; Vogt VM
    J Virol; 1997 Jun; 71(6):4425-35. PubMed ID: 9151833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.
    Rye-McCurdy TD; Nadaraia-Hoke S; Gudleski-O'Regan N; Flanagan JM; Parent LJ; Musier-Forsyth K
    J Virol; 2014 Jul; 88(14):7852-61. PubMed ID: 24789780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.
    Wiegers K; Rutter G; Kottler H; Tessmer U; Hohenberg H; Kräusslich HG
    J Virol; 1998 Apr; 72(4):2846-54. PubMed ID: 9525604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The retroviral capsid domain dictates virion size, morphology, and coassembly of gag into virus-like particles.
    Ako-Adjei D; Johnson MC; Vogt VM
    J Virol; 2005 Nov; 79(21):13463-72. PubMed ID: 16227267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation.
    Zhang Y; Barklis E
    J Virol; 1995 Sep; 69(9):5716-22. PubMed ID: 7637017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrodynamic and Membrane Binding Properties of Purified Rous Sarcoma Virus Gag Protein.
    Dick RA; Datta SA; Nanda H; Fang X; Wen Y; Barros M; Wang YX; Rein A; Vogt VM
    J Virol; 2015 Oct; 89(20):10371-82. PubMed ID: 26246573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.
    Campbell S; Rein A
    J Virol; 1999 Mar; 73(3):2270-9. PubMed ID: 9971810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.
    Poon DT; Li G; Aldovini A
    J Virol; 1998 Mar; 72(3):1983-93. PubMed ID: 9499052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assembly of human immunodeficiency virus type 1 Gag protein.
    Morikawa Y; Goto T; Sano K
    J Biol Chem; 1999 Sep; 274(39):27997-8002. PubMed ID: 10488150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding.
    Keller PW; Johnson MC; Vogt VM
    J Virol; 2008 Jul; 82(14):6788-97. PubMed ID: 18448521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Rous sarcoma virus Gag protein by mass spectrometry indicates trimming by host exopeptidase.
    Pepinsky RB; Papayannopoulos IA; Campbell S; Vogt VM
    J Virol; 1996 May; 70(5):3313-8. PubMed ID: 8627817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo.
    Berkowitz RD; Ohagen A; Höglund S; Goff SP
    J Virol; 1995 Oct; 69(10):6445-56. PubMed ID: 7666546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.